We refer you to the Underwriting section beginning on page 195 of this prospectus for additional information regarding underwritingĬertain of our existing security holders and certain of our directors, and their respective affiliated entities, have Underwriting discounts and commissions(1) See Risk Factors beginning on page 13 to read about factors you should consider before buying shares of our common stock. We are an emerging growth company and a smaller reporting company as defined under the federal securities laws and, as such, have elected toĬomply with certain reduced reporting requirements for this prospectus and may elect to do so in future filings. We intend to apply to list our common stock on The Nasdaq Global Market under the symbol NEXI.Īnticipate that the initial public offering price will be between $ and $ per share. No public market currently exists for our common stock. This is an initial public offering of shares of the common stock of NexImmune, Inc. SUBJECT TO COMPLETION, DATED JANUARY 19, 2021 Where the offer or sale is not permitted. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction
#Trials fusion base invader registration
Securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. The information in this preliminary prospectus is not complete and may be changed. Registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine. The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effectiveĭate until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this
Includes initial public offering price of shares that the underwriters may purchase pursuant to an option to purchase additional shares.Įstimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.Ĭalculated pursuant to Rule 457(o) based on an estimate of the proposed maximum aggregate initial public offering price. Title of Each Class of Securities to be RegisteredĬommon stock, $0.0001 par value per share
Period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition See the definitions of large accelerated filer, accelerated filer, smaller reportingĬompany and emerging growth company in Rule 12b-2 of the Exchange Act. Non-accelerated filer, a smaller reporting company or an emerging growth company. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a If this Form is a post-effective amendment filed pursuant to RuleĤ62(d) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlierĮffective registration statement for the same offering. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following boxĪnd list the Securities Act registration statement number of the earlier effective registration statement for the same offering. The securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.Īpproximate date of commencement of proposed sale to the public:Īs soon as practicable after the effective date of this registration statement.
#Trials fusion base invader zip
Including zip code, and telephone number, including area code, of agent for service) Of registrants principal executive offices) (Address, including zip code, and telephone number, including area code, (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on January 19, 2021
0 kommentar(er)
